Abbott grows cardiac portfolio with Amplatzer approval for valve leaks

Abbott wins FDA approval for Amplatzer Paraclose device to treat heart valve leaks

Abbott received FDA approval for its Amplatzer Paraclose PVL Occluder, the first transcatheter device designed to close paravalvular leaks around surgical replacement heart valves without requiring additional open-heart surgery.